Aeglea BioTherapeutics
Eric Bradford, MD, MSc, MBA, is the Chief Medical Officer at Areteia Therapeutics. Prior to this role, Eric held positions at Aeglea BioTherapeutics and GSK, where Eric gained extensive experience in clinical development and global product strategy. Eric's academic background includes degrees from Stanford University, University of Virginia, and University of North Carolina at Chapel Hill School of Medicine.
This person is not in any offices
Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.